

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * sarcomere organization (GO:0045214) | 7.82181657 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 7.59425237 |
| 3 | * cardiac myofibril assembly (GO:0055003) | 7.43131069 |
| 4 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 7.06978486 |
| 5 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.81922887 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.46651084 |
| 7 | * myofibril assembly (GO:0030239) | 6.44609908 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.28001069 |
| 9 | cardiac muscle contraction (GO:0060048) | 6.26215720 |
| 10 | cardiac muscle cell development (GO:0055013) | 6.17069848 |
| 11 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.08820330 |
| 12 | cardiac cell development (GO:0055006) | 5.79042392 |
| 13 | ventricular cardiac muscle cell action potential (GO:0086005) | 5.76326109 |
| 14 | tricarboxylic acid cycle (GO:0006099) | 5.69488119 |
| 15 | muscle filament sliding (GO:0030049) | 5.63563664 |
| 16 | actin-myosin filament sliding (GO:0033275) | 5.63563664 |
| 17 | regulation of actin filament-based movement (GO:1903115) | 5.60270618 |
| 18 | plasma membrane repair (GO:0001778) | 5.50222297 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.47841387 |
| 20 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 5.47078339 |
| 21 | regulation of relaxation of muscle (GO:1901077) | 5.30779961 |
| 22 | adult heart development (GO:0007512) | 5.15051373 |
| 23 | cardiac muscle hypertrophy (GO:0003300) | 5.12244042 |
| 24 | cell communication involved in cardiac conduction (GO:0086065) | 5.05352907 |
| 25 | regulation of membrane repolarization (GO:0060306) | 5.03555336 |
| 26 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.00008764 |
| 27 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.99862901 |
| 28 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.99012266 |
| 29 | * actomyosin structure organization (GO:0031032) | 4.96763570 |
| 30 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 4.91873168 |
| 31 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.86865836 |
| 32 | striated muscle hypertrophy (GO:0014897) | 4.85474954 |
| 33 | actin-mediated cell contraction (GO:0070252) | 4.83546794 |
| 34 | regulation of sarcomere organization (GO:0060297) | 4.78572125 |
| 35 | cell communication by electrical coupling (GO:0010644) | 4.78101108 |
| 36 | striated muscle contraction (GO:0006941) | 4.70394566 |
| 37 | carnitine shuttle (GO:0006853) | 4.66221853 |
| 38 | heart trabecula formation (GO:0060347) | 4.65546839 |
| 39 | regulation of cell communication by electrical coupling (GO:0010649) | 4.63521677 |
| 40 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.62220566 |
| 41 | regulation of skeletal muscle contraction (GO:0014819) | 4.58046849 |
| 42 | regulation of striated muscle contraction (GO:0006942) | 4.56287304 |
| 43 | regulation of the force of heart contraction (GO:0002026) | 4.54556240 |
| 44 | cardiac chamber formation (GO:0003207) | 4.49162685 |
| 45 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.48537751 |
| 46 | muscle tissue morphogenesis (GO:0060415) | 4.46197344 |
| 47 | regulation of cardioblast differentiation (GO:0051890) | 4.40401185 |
| 48 | relaxation of cardiac muscle (GO:0055119) | 4.20634645 |
| 49 | muscle hypertrophy (GO:0014896) | 4.18594835 |
| 50 | heart process (GO:0003015) | 4.14297618 |
| 51 | heart contraction (GO:0060047) | 4.14297618 |
| 52 | regulation of cofactor metabolic process (GO:0051193) | 4.11353781 |
| 53 | regulation of coenzyme metabolic process (GO:0051196) | 4.11353781 |
| 54 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.08790760 |
| 55 | cardiac ventricle formation (GO:0003211) | 4.08694605 |
| 56 | cardiac muscle cell action potential (GO:0086001) | 4.05703991 |
| 57 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 4.05337703 |
| 58 | regulation of cardiac muscle contraction (GO:0055117) | 4.05147839 |
| 59 | negative regulation of potassium ion transport (GO:0043267) | 3.96703701 |
| 60 | regulation of heart rate (GO:0002027) | 3.93900095 |
| 61 | response to inactivity (GO:0014854) | 3.93057517 |
| 62 | fatty acid transmembrane transport (GO:1902001) | 3.91041176 |
| 63 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.86244723 |
| 64 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.85421169 |
| 65 | cardiac conduction (GO:0061337) | 3.78200720 |
| 66 | detection of calcium ion (GO:0005513) | 3.74408085 |
| 67 | ventricular cardiac muscle cell development (GO:0055015) | 3.73927092 |
| 68 | actin filament-based movement (GO:0030048) | 3.71307306 |
| 69 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.68842054 |
| 70 | muscle hypertrophy in response to stress (GO:0003299) | 3.68842054 |
| 71 | cardiac muscle adaptation (GO:0014887) | 3.68842054 |
| 72 | atrial septum morphogenesis (GO:0060413) | 3.66714474 |
| 73 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.66236761 |
| 74 | regulation of heart contraction (GO:0008016) | 3.64268944 |
| 75 | potassium ion export (GO:0071435) | 3.55792765 |
| 76 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.51504518 |
| 77 | positive regulation of cation channel activity (GO:2001259) | 3.48050728 |
| 78 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.46162088 |
| 79 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.46162088 |
| 80 | positive regulation of heart contraction (GO:0045823) | 3.45165885 |
| 81 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.44830613 |
| 82 | striated muscle cell development (GO:0055002) | 3.43012290 |
| 83 | regulation of ATPase activity (GO:0043462) | 3.39187869 |
| 84 | regulation of ATP catabolic process (GO:1903289) | 3.39187869 |
| 85 | carnitine transmembrane transport (GO:1902603) | 3.38224169 |
| 86 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.38197591 |
| 87 | NADH metabolic process (GO:0006734) | 3.36350647 |
| 88 | regulation of sulfur metabolic process (GO:0042762) | 3.36230095 |
| 89 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.36119908 |
| 90 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.35546185 |
| 91 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.34600479 |
| 92 | negative regulation of protein localization to cell surface (GO:2000009) | 3.31117462 |
| 93 | positive regulation of heart rate (GO:0010460) | 3.26102238 |
| 94 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.24706948 |
| 95 | oxygen transport (GO:0015671) | 3.24313352 |
| 96 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.13844425 |
| 97 | muscle cell cellular homeostasis (GO:0046716) | 3.12898169 |
| 98 | muscle system process (GO:0003012) | 3.12671950 |
| 99 | amino-acid betaine transport (GO:0015838) | 3.12515937 |
| 100 | carnitine transport (GO:0015879) | 3.12515937 |
| 101 | 2-oxoglutarate metabolic process (GO:0006103) | 3.09248958 |
| 102 | muscle contraction (GO:0006936) | 3.09169354 |
| 103 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.08297029 |
| 104 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.08031747 |
| 105 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.07900781 |
| 106 | membrane repolarization during action potential (GO:0086011) | 3.06942172 |
| 107 | striated muscle adaptation (GO:0014888) | 3.04527165 |
| 108 | response to muscle activity (GO:0014850) | 3.03974352 |
| 109 | regulation of muscle contraction (GO:0006937) | 3.02821530 |
| 110 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.99606156 |
| 111 | cardiac muscle tissue development (GO:0048738) | 2.97241983 |
| 112 | muscle cell development (GO:0055001) | 2.92968794 |
| 113 | atrioventricular valve morphogenesis (GO:0003181) | 2.92954711 |
| 114 | regulation of cardiac muscle cell differentiation (GO:2000725) | 2.92256221 |
| 115 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 2.90420960 |
| 116 | adrenergic receptor signaling pathway (GO:0071875) | 2.90416668 |
| 117 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.89206019 |
| 118 | regulation of muscle system process (GO:0090257) | 2.87021172 |
| 119 | cellular response to epinephrine stimulus (GO:0071872) | 2.83582582 |
| 120 | response to epinephrine (GO:0071871) | 2.82929749 |
| 121 | positive regulation of cardiac muscle tissue development (GO:0055025) | 2.81555380 |
| 122 | muscle fiber development (GO:0048747) | 2.80748467 |
| 123 | relaxation of muscle (GO:0090075) | 2.76339174 |
| 124 | response to caffeine (GO:0031000) | 2.75726115 |
| 125 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 2.74867129 |
| 126 | skeletal muscle contraction (GO:0003009) | 2.74121194 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 4.25765806 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.88673691 |
| 3 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.54704892 |
| 4 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.09649619 |
| 5 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.09649619 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.07163805 |
| 7 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.93926014 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.85018165 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.79408831 |
| 10 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.53604666 |
| 11 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.51810990 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13660999 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.08073136 |
| 14 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.03299906 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.98091141 |
| 16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.91218350 |
| 17 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.90638273 |
| 18 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.75599721 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.69964725 |
| 20 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.66462693 |
| 21 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.66013975 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64666536 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.59141523 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.56496492 |
| 25 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.53856956 |
| 26 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47585937 |
| 27 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.45634027 |
| 28 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.41670965 |
| 29 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.41670965 |
| 30 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.41429879 |
| 31 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40840860 |
| 32 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.37084220 |
| 33 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.36331298 |
| 34 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36151546 |
| 35 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.35966763 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.35789357 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.34689906 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.33985287 |
| 39 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.33329566 |
| 40 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.30586115 |
| 41 | * SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.28578280 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.28532173 |
| 43 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.27480820 |
| 44 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.26665421 |
| 45 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.26207256 |
| 46 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.25979826 |
| 47 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25734100 |
| 48 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.23596777 |
| 49 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.21686717 |
| 50 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.20928208 |
| 51 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.19875939 |
| 52 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19222017 |
| 53 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.19205611 |
| 54 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18286450 |
| 55 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.18131667 |
| 56 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.17569805 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17471083 |
| 58 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17286502 |
| 59 | * DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.16081021 |
| 60 | KDM2B_26808549_Chip-Seq_K562_Human | 1.15729457 |
| 61 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14565001 |
| 62 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.14420282 |
| 63 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14126991 |
| 64 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.13128703 |
| 65 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12538757 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11948424 |
| 67 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.11279184 |
| 68 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11185782 |
| 69 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.10488795 |
| 70 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.10249990 |
| 71 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10023056 |
| 72 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09538840 |
| 73 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.09442176 |
| 74 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08652415 |
| 75 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.07732036 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.07624176 |
| 77 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.07422376 |
| 78 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.06731942 |
| 79 | * AR_19668381_ChIP-Seq_PC3_Human | 1.05789902 |
| 80 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05629629 |
| 81 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.04949604 |
| 82 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04631428 |
| 83 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.03426687 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03001541 |
| 85 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02831568 |
| 86 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.02500962 |
| 87 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.02490742 |
| 88 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.02480000 |
| 89 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02356030 |
| 90 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.02187816 |
| 91 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.02000629 |
| 92 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.01361992 |
| 93 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.00554481 |
| 94 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.00453921 |
| 95 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.00338591 |
| 96 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99923820 |
| 97 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.99467274 |
| 98 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.98210204 |
| 99 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.97846800 |
| 100 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.97282430 |
| 101 | SOX9_26525672_Chip-Seq_HEART_Mouse | 0.96224147 |
| 102 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.95760831 |
| 103 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.93514363 |
| 104 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.93077555 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.91745657 |
| 106 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.90158826 |
| 107 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89992725 |
| 108 | TBL1_22424771_ChIP-Seq_293T_Human | 0.89871392 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.89320911 |
| 110 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.89218165 |
| 111 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.89009840 |
| 112 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.89008969 |
| 113 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88942785 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.87879644 |
| 115 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.87645157 |
| 116 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.87135822 |
| 117 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87091452 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.87027678 |
| 119 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.85766769 |
| 120 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.85273845 |
| 121 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.85073408 |
| 122 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.83855874 |
| 123 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83793957 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83465717 |
| 125 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83401270 |
| 126 | ATF3_27146783_Chip-Seq_COLON_Human | 0.82328622 |
| 127 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.82130189 |
| 128 | CJUN_26792858_Chip-Seq_BT549_Human | 0.82046719 |
| 129 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81416204 |
| 130 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.81217098 |
| 131 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.80976110 |
| 132 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.79331229 |
| 133 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78272367 |
| 134 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.77254305 |
| 135 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.77112732 |
| 136 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77089422 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 6.80961469 |
| 2 | MP0003646_muscle_fatigue | 5.80763055 |
| 3 | MP0004084_abnormal_cardiac_muscle | 5.64375403 |
| 4 | MP0000751_myopathy | 4.91808397 |
| 5 | MP0004215_abnormal_myocardial_fiber | 4.88444467 |
| 6 | MP0004036_abnormal_muscle_relaxation | 4.12582752 |
| 7 | MP0005330_cardiomyopathy | 3.67258678 |
| 8 | MP0000749_muscle_degeneration | 3.34801446 |
| 9 | MP0002972_abnormal_cardiac_muscle | 3.10353137 |
| 10 | MP0003137_abnormal_impulse_conducting | 2.95455893 |
| 11 | MP0004087_abnormal_muscle_fiber | 2.88917143 |
| 12 | MP0008775_abnormal_heart_ventricle | 2.85264260 |
| 13 | MP0005620_abnormal_muscle_contractility | 2.69015219 |
| 14 | MP0004484_altered_response_of | 2.51070831 |
| 15 | MP0000750_abnormal_muscle_regeneration | 2.47881429 |
| 16 | MP0005385_cardiovascular_system_phenoty | 2.45273356 |
| 17 | MP0001544_abnormal_cardiovascular_syste | 2.45273356 |
| 18 | MP0010630_abnormal_cardiac_muscle | 2.44909787 |
| 19 | MP0006138_congestive_heart_failure | 2.38336147 |
| 20 | MP0002106_abnormal_muscle_physiology | 2.34760030 |
| 21 | MP0004130_abnormal_muscle_cell | 2.33201974 |
| 22 | MP0004085_abnormal_heartbeat | 2.28915207 |
| 23 | MP0004145_abnormal_muscle_electrophysio | 2.22670615 |
| 24 | MP0002269_muscular_atrophy | 2.14427530 |
| 25 | MP0004510_myositis | 1.98396448 |
| 26 | MP0003828_pulmonary_edema | 1.95738141 |
| 27 | MP0004233_abnormal_muscle_weight | 1.91579227 |
| 28 | MP0005369_muscle_phenotype | 1.87854193 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 1.87182965 |
| 30 | MP0000747_muscle_weakness | 1.73595014 |
| 31 | MP0002127_abnormal_cardiovascular_syste | 1.73389260 |
| 32 | MP0000759_abnormal_skeletal_muscle | 1.72842423 |
| 33 | MP0003950_abnormal_plasma_membrane | 1.44790753 |
| 34 | MP0002234_abnormal_pharynx_morphology | 1.35451484 |
| 35 | MP0006036_abnormal_mitochondrial_physio | 1.31644774 |
| 36 | MP0005666_abnormal_adipose_tissue | 1.27685874 |
| 37 | MP0002332_abnormal_exercise_endurance | 1.26378119 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.21067718 |
| 39 | MP0000266_abnormal_heart_morphology | 1.13087107 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.12811372 |
| 41 | MP0010030_abnormal_orbit_morphology | 1.10538065 |
| 42 | MP0010368_abnormal_lymphatic_system | 1.06713430 |
| 43 | MP0005451_abnormal_body_composition | 1.05987343 |
| 44 | MP0002909_abnormal_adrenal_gland | 1.03910675 |
| 45 | MP0004043_abnormal_pH_regulation | 0.99206020 |
| 46 | MP0008438_abnormal_cutaneous_collagen | 0.98363936 |
| 47 | MP0005623_abnormal_meninges_morphology | 0.96782571 |
| 48 | MP0005503_abnormal_tendon_morphology | 0.94958344 |
| 49 | MP0001661_extended_life_span | 0.91879953 |
| 50 | MP0005375_adipose_tissue_phenotype | 0.87382553 |
| 51 | MP0005165_increased_susceptibility_to | 0.86754177 |
| 52 | MP0000762_abnormal_tongue_morphology | 0.85408517 |
| 53 | MP0005187_abnormal_penis_morphology | 0.85192380 |
| 54 | MP0005670_abnormal_white_adipose | 0.83630532 |
| 55 | MP0000778_abnormal_nervous_system | 0.82867604 |
| 56 | MP0009780_abnormal_chondrocyte_physiolo | 0.82105839 |
| 57 | MP0000230_abnormal_systemic_arterial | 0.82102889 |
| 58 | MP0001984_abnormal_olfaction | 0.82006574 |
| 59 | MP0003283_abnormal_digestive_organ | 0.81888356 |
| 60 | MP0000537_abnormal_urethra_morphology | 0.79661162 |
| 61 | MP0005275_abnormal_skin_tensile | 0.78227674 |
| 62 | MP0005423_abnormal_somatic_nervous | 0.77612275 |
| 63 | MP0006035_abnormal_mitochondrial_morpho | 0.76440573 |
| 64 | MP0000534_abnormal_ureter_morphology | 0.74743508 |
| 65 | MP0000462_abnormal_digestive_system | 0.73221338 |
| 66 | MP0000343_altered_response_to | 0.72286454 |
| 67 | MP0006072_abnormal_retinal_apoptosis | 0.71515495 |
| 68 | MP0009250_abnormal_appendicular_skeleto | 0.71107963 |
| 69 | MP0003385_abnormal_body_wall | 0.69160730 |
| 70 | MP0000049_abnormal_middle_ear | 0.68952027 |
| 71 | MP0008789_abnormal_olfactory_epithelium | 0.68914530 |
| 72 | MP0001958_emphysema | 0.67763218 |
| 73 | MP0004859_abnormal_synaptic_plasticity | 0.67740070 |
| 74 | MP0004924_abnormal_behavior | 0.67529964 |
| 75 | MP0005386_behavior/neurological_phenoty | 0.67529964 |
| 76 | MP0003705_abnormal_hypodermis_morpholog | 0.66125800 |
| 77 | MP0008961_abnormal_basal_metabolism | 0.65650748 |
| 78 | MP0002102_abnormal_ear_morphology | 0.65589999 |
| 79 | MP0000003_abnormal_adipose_tissue | 0.65498575 |
| 80 | MP0005409_darkened_coat_color | 0.65456937 |
| 81 | MP0002108_abnormal_muscle_morphology | 0.65296458 |
| 82 | MP0002128_abnormal_blood_circulation | 0.64494622 |
| 83 | MP0003279_aneurysm | 0.64074483 |
| 84 | MP0005266_abnormal_metabolism | 0.63958389 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.63028525 |
| 86 | MP0002822_catalepsy | 0.62480037 |
| 87 | MP0006276_abnormal_autonomic_nervous | 0.62052987 |
| 88 | MP0005499_abnormal_olfactory_system | 0.61965204 |
| 89 | MP0005394_taste/olfaction_phenotype | 0.61965204 |
| 90 | MP0002896_abnormal_bone_mineralization | 0.61730599 |
| 91 | MP0000013_abnormal_adipose_tissue | 0.61095761 |
| 92 | MP0003942_abnormal_urinary_system | 0.57424127 |
| 93 | MP0002249_abnormal_larynx_morphology | 0.56877195 |
| 94 | MP0002877_abnormal_melanocyte_morpholog | 0.56729856 |
| 95 | MP0000428_abnormal_craniofacial_morphol | 0.56235981 |
| 96 | MP0003566_abnormal_cell_adhesion | 0.55679167 |
| 97 | MP0003937_abnormal_limbs/digits/tail_de | 0.55405091 |
| 98 | MP0000579_abnormal_nail_morphology | 0.55008355 |
| 99 | MP0003755_abnormal_palate_morphology | 0.54735398 |
| 100 | MP0005248_abnormal_Harderian_gland | 0.54493660 |
| 101 | MP0003941_abnormal_skin_development | 0.54341459 |
| 102 | MP0000566_synostosis | 0.53742254 |
| 103 | MP0002233_abnormal_nose_morphology | 0.53272501 |
| 104 | MP0002078_abnormal_glucose_homeostasis | 0.52962348 |
| 105 | MP0004270_analgesia | 0.52946037 |
| 106 | MP0003880_abnormal_central_pattern | 0.51757329 |
| 107 | MP0006292_abnormal_olfactory_placode | 0.50893967 |
| 108 | MP0002925_abnormal_cardiovascular_devel | 0.49832454 |
| 109 | MP0003984_embryonic_growth_retardation | 0.49547387 |
| 110 | MP0000767_abnormal_smooth_muscle | 0.48965487 |
| 111 | MP0002088_abnormal_embryonic_growth/wei | 0.48108445 |
| 112 | MP0000733_abnormal_muscle_development | 0.45764268 |
| 113 | MP0004272_abnormal_basement_membrane | 0.45505837 |
| 114 | MP0001784_abnormal_fluid_regulation | 0.42192988 |
| 115 | MP0003635_abnormal_synaptic_transmissio | 0.41802614 |
| 116 | MP0002971_abnormal_brown_adipose | 0.37379918 |
| 117 | MP0005551_abnormal_eye_electrophysiolog | 0.34961475 |
| 118 | MP0001529_abnormal_vocalization | 0.34495526 |
| 119 | MP0005535_abnormal_body_temperature | 0.33841633 |
| 120 | MP0001672_abnormal_embryogenesis/_devel | 0.33518523 |
| 121 | MP0005380_embryogenesis_phenotype | 0.33518523 |
| 122 | MP0001299_abnormal_eye_distance/ | 0.31863853 |
| 123 | MP0009384_cardiac_valve_regurgitation | 0.31691049 |
| 124 | MP0001614_abnormal_blood_vessel | 0.30825637 |
| 125 | MP0001765_abnormal_ion_homeostasis | 0.27411863 |
| 126 | MP0003935_abnormal_craniofacial_develop | 0.27365317 |
| 127 | MP0003045_fibrosis | 0.27066461 |
| 128 | MP0008569_lethality_at_weaning | 0.26747416 |
| 129 | MP0004858_abnormal_nervous_system | 0.26530671 |
| 130 | MP0001879_abnormal_lymphatic_vessel | 0.26489206 |
| 131 | MP0003948_abnormal_gas_homeostasis | 0.25542476 |
| 132 | MP0002063_abnormal_learning/memory/cond | 0.24022728 |
| 133 | MP0010386_abnormal_urinary_bladder | 0.23326572 |
| 134 | MP0002734_abnormal_mechanical_nocicepti | 0.22151395 |
| 135 | MP0002272_abnormal_nervous_system | 0.20552448 |
| 136 | MP0001727_abnormal_embryo_implantation | 0.20500470 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 8.68888281 |
| 2 | Ventricular tachycardia (HP:0004756) | 6.91168291 |
| 3 | Atrial fibrillation (HP:0005110) | 6.37107162 |
| 4 | Primary atrial arrhythmia (HP:0001692) | 5.98564701 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 5.95705551 |
| 6 | Supraventricular tachycardia (HP:0004755) | 5.74704934 |
| 7 | Supraventricular arrhythmia (HP:0005115) | 5.63567301 |
| 8 | Syncope (HP:0001279) | 5.47621837 |
| 9 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.39692295 |
| 10 | Muscle fiber splitting (HP:0003555) | 5.33101732 |
| 11 | Exercise-induced muscle cramps (HP:0003710) | 5.24970800 |
| 12 | Exercise-induced myalgia (HP:0003738) | 5.24115893 |
| 13 | Lipoatrophy (HP:0100578) | 5.23293703 |
| 14 | Bundle branch block (HP:0011710) | 5.15854219 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 5.15724838 |
| 16 | Subaortic stenosis (HP:0001682) | 5.14835938 |
| 17 | Abnormality of the left ventricular outflow tract (HP:0011103) | 5.14835938 |
| 18 | Right ventricular cardiomyopathy (HP:0011663) | 5.08970438 |
| 19 | Prolonged QT interval (HP:0001657) | 4.74422116 |
| 20 | Ventricular fibrillation (HP:0001663) | 4.55900331 |
| 21 | Hyporeflexia of lower limbs (HP:0002600) | 4.54822823 |
| 22 | Ventricular arrhythmia (HP:0004308) | 4.39563819 |
| 23 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.30795037 |
| 24 | Dilated cardiomyopathy (HP:0001644) | 4.25265217 |
| 25 | Muscle fiber inclusion bodies (HP:0100299) | 4.25174768 |
| 26 | Myoglobinuria (HP:0002913) | 4.23786018 |
| 27 | Palpitations (HP:0001962) | 4.18110920 |
| 28 | Heart block (HP:0012722) | 4.09541254 |
| 29 | Nemaline bodies (HP:0003798) | 4.06095785 |
| 30 | Atrioventricular block (HP:0001678) | 4.00032960 |
| 31 | Asymmetric septal hypertrophy (HP:0001670) | 3.91409689 |
| 32 | Abnormal atrioventricular conduction (HP:0005150) | 3.83368930 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 3.80980160 |
| 34 | Abnormal EKG (HP:0003115) | 3.44608037 |
| 35 | Left ventricular hypertrophy (HP:0001712) | 3.39543187 |
| 36 | Increased connective tissue (HP:0009025) | 3.30099244 |
| 37 | Myotonia (HP:0002486) | 3.28721882 |
| 38 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.27031368 |
| 39 | Difficulty running (HP:0009046) | 3.21532333 |
| 40 | Rhabdomyolysis (HP:0003201) | 2.99409355 |
| 41 | Ketoacidosis (HP:0001993) | 2.95124607 |
| 42 | Difficulty climbing stairs (HP:0003551) | 2.67936295 |
| 43 | Central scotoma (HP:0000603) | 2.67362802 |
| 44 | Palmoplantar keratoderma (HP:0000982) | 2.62819058 |
| 45 | Hip contracture (HP:0003273) | 2.50811033 |
| 46 | Dysmetric saccades (HP:0000641) | 2.48855425 |
| 47 | Hypoglycemic coma (HP:0001325) | 2.31333520 |
| 48 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.31188154 |
| 49 | Limited hip movement (HP:0008800) | 2.25811767 |
| 50 | Pheochromocytoma (HP:0002666) | 2.22604087 |
| 51 | Acute necrotizing encephalopathy (HP:0006965) | 2.22350834 |
| 52 | Hypoplastic left heart (HP:0004383) | 2.20314966 |
| 53 | Testicular atrophy (HP:0000029) | 2.20014193 |
| 54 | Increased variability in muscle fiber diameter (HP:0003557) | 2.18278693 |
| 55 | Hepatic necrosis (HP:0002605) | 2.18149468 |
| 56 | Aortic aneurysm (HP:0004942) | 2.17146320 |
| 57 | Ragged-red muscle fibers (HP:0003200) | 2.15473378 |
| 58 | EMG: neuropathic changes (HP:0003445) | 2.14238489 |
| 59 | Conjunctival hamartoma (HP:0100780) | 2.12142009 |
| 60 | Sudden cardiac death (HP:0001645) | 2.11843541 |
| 61 | Distal arthrogryposis (HP:0005684) | 2.11064975 |
| 62 | Neck muscle weakness (HP:0000467) | 2.09901347 |
| 63 | Limb-girdle muscle atrophy (HP:0003797) | 2.09749796 |
| 64 | Hamartoma of the eye (HP:0010568) | 2.08813338 |
| 65 | Areflexia of lower limbs (HP:0002522) | 2.04114651 |
| 66 | Hypoplastic ischia (HP:0003175) | 2.03780643 |
| 67 | Myopathic facies (HP:0002058) | 2.03649525 |
| 68 | Spinal rigidity (HP:0003306) | 2.03177824 |
| 69 | Protrusio acetabuli (HP:0003179) | 2.01766324 |
| 70 | Abnormality of the foot musculature (HP:0001436) | 2.01138563 |
| 71 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.00684758 |
| 72 | Round ear (HP:0100830) | 2.00355800 |
| 73 | Hyperglycemia (HP:0003074) | 1.99838447 |
| 74 | Hypoplastic heart (HP:0001961) | 1.98041666 |
| 75 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.97100818 |
| 76 | Large for gestational age (HP:0001520) | 1.96459625 |
| 77 | Myokymia (HP:0002411) | 1.95706037 |
| 78 | Steppage gait (HP:0003376) | 1.95045111 |
| 79 | Distal lower limb muscle weakness (HP:0009053) | 1.94362316 |
| 80 | Bradycardia (HP:0001662) | 1.93966157 |
| 81 | Abnormality of alanine metabolism (HP:0010916) | 1.92265578 |
| 82 | Hyperalaninemia (HP:0003348) | 1.92265578 |
| 83 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.92265578 |
| 84 | Muscle stiffness (HP:0003552) | 1.92231827 |
| 85 | Congestive heart failure (HP:0001635) | 1.90306367 |
| 86 | Acute encephalopathy (HP:0006846) | 1.89878060 |
| 87 | Vascular tortuosity (HP:0004948) | 1.89440661 |
| 88 | Progressive macrocephaly (HP:0004481) | 1.88794029 |
| 89 | Arterial tortuosity (HP:0005116) | 1.88710586 |
| 90 | Neuroendocrine neoplasm (HP:0100634) | 1.88079572 |
| 91 | Gowers sign (HP:0003391) | 1.85888396 |
| 92 | Neoplasm of the adrenal gland (HP:0100631) | 1.84725102 |
| 93 | Foot dorsiflexor weakness (HP:0009027) | 1.84124851 |
| 94 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.83038212 |
| 95 | Ketosis (HP:0001946) | 1.82805314 |
| 96 | Hepatocellular necrosis (HP:0001404) | 1.81981453 |
| 97 | Type 1 muscle fiber predominance (HP:0003803) | 1.81882838 |
| 98 | Scotoma (HP:0000575) | 1.80293919 |
| 99 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.79486476 |
| 100 | Lower limb amyotrophy (HP:0007210) | 1.79165030 |
| 101 | Muscular dystrophy (HP:0003560) | 1.77633405 |
| 102 | Double outlet right ventricle (HP:0001719) | 1.77424854 |
| 103 | Congenital malformation of the right heart (HP:0011723) | 1.77424854 |
| 104 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.76914946 |
| 105 | Scapular winging (HP:0003691) | 1.75774176 |
| 106 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.75465206 |
| 107 | Abnormality of the ischium (HP:0003174) | 1.75353424 |
| 108 | Dicarboxylic aciduria (HP:0003215) | 1.74071535 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.74071535 |
| 110 | Increased muscle lipid content (HP:0009058) | 1.73911245 |
| 111 | Frequent falls (HP:0002359) | 1.73348392 |
| 112 | Lymphangioma (HP:0100764) | 1.71960519 |
| 113 | Waddling gait (HP:0002515) | 1.71850314 |
| 114 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.70266644 |
| 115 | Athetosis (HP:0002305) | 1.68819055 |
| 116 | Abnormality of the tricuspid valve (HP:0001702) | 1.68347514 |
| 117 | Tinnitus (HP:0000360) | 1.67400830 |
| 118 | Preauricular pit (HP:0004467) | 1.66725038 |
| 119 | Periauricular skin pits (HP:0100277) | 1.66725038 |
| 120 | Rimmed vacuoles (HP:0003805) | 1.65781285 |
| 121 | Skin pits (HP:0100276) | 1.65753273 |
| 122 | Distal lower limb amyotrophy (HP:0008944) | 1.64561793 |
| 123 | Mitochondrial inheritance (HP:0001427) | 1.63987089 |
| 124 | Cerebral edema (HP:0002181) | 1.63375600 |
| 125 | Proximal amyotrophy (HP:0007126) | 1.62522390 |
| 126 | Calcaneovalgus deformity (HP:0001848) | 1.62147857 |
| 127 | Increased CSF lactate (HP:0002490) | 1.59830873 |
| 128 | Ulnar deviation of the wrist (HP:0003049) | 1.59671420 |
| 129 | Generalized muscle weakness (HP:0003324) | 1.58848821 |
| 130 | Limb-girdle muscle weakness (HP:0003325) | 1.58682294 |
| 131 | Turricephaly (HP:0000262) | 1.58114810 |
| 132 | Anomalous pulmonary venous return (HP:0010772) | 1.51299622 |
| 133 | Absent phalangeal crease (HP:0006109) | 1.51160648 |
| 134 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.47225192 |
| 135 | Deformed tarsal bones (HP:0008119) | 1.44003576 |
| 136 | Skin nodule (HP:0200036) | 1.43527982 |
| 137 | Aplasia of the musculature (HP:0100854) | 1.43104457 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 4.59844834 |
| 2 | PHKG1 | 3.65931276 |
| 3 | PHKG2 | 3.65931276 |
| 4 | LMTK2 | 3.56843244 |
| 5 | DMPK | 3.41842725 |
| 6 | OBSCN | 3.41481246 |
| 7 | MYLK | 3.26761690 |
| 8 | PDK4 | 2.99095826 |
| 9 | PDK3 | 2.99095826 |
| 10 | PKN2 | 2.83507603 |
| 11 | TRIB3 | 2.48183621 |
| 12 | NEK1 | 2.30444793 |
| 13 | MUSK | 2.23866292 |
| 14 | EPHB2 | 2.20515544 |
| 15 | LATS2 | 2.09779099 |
| 16 | STK38L | 2.04437228 |
| 17 | LATS1 | 2.00367207 |
| 18 | STK24 | 1.97911336 |
| 19 | PIK3CA | 1.97562634 |
| 20 | PINK1 | 1.86873144 |
| 21 | PAK3 | 1.70091043 |
| 22 | PDK2 | 1.58863902 |
| 23 | STK38 | 1.49544459 |
| 24 | NEK9 | 1.47945499 |
| 25 | PRKD3 | 1.47034721 |
| 26 | LIMK1 | 1.41808836 |
| 27 | MAP3K4 | 1.41251256 |
| 28 | TIE1 | 1.39385857 |
| 29 | KSR2 | 1.30458433 |
| 30 | WNK4 | 1.30006778 |
| 31 | PAK6 | 1.26767864 |
| 32 | BCKDK | 1.24508539 |
| 33 | CAMK2D | 1.23332285 |
| 34 | MAP3K9 | 1.22918378 |
| 35 | TAOK1 | 1.21788018 |
| 36 | PRKD1 | 1.19285683 |
| 37 | CDC42BPA | 1.18914711 |
| 38 | MAP3K6 | 1.17257146 |
| 39 | PRKAA1 | 1.13334108 |
| 40 | ILK | 1.11311447 |
| 41 | CASK | 1.11014881 |
| 42 | MAP3K5 | 1.10610354 |
| 43 | GRK7 | 1.08122794 |
| 44 | ROCK1 | 1.01931189 |
| 45 | NTRK1 | 0.99030528 |
| 46 | RIPK1 | 0.95107384 |
| 47 | DDR2 | 0.93926732 |
| 48 | NTRK2 | 0.92467143 |
| 49 | INSRR | 0.87651679 |
| 50 | PTK2 | 0.87271884 |
| 51 | PDGFRA | 0.86231824 |
| 52 | CAMK2A | 0.84242209 |
| 53 | PRKAA2 | 0.83814051 |
| 54 | MAP3K7 | 0.83507247 |
| 55 | MAPKAPK3 | 0.81031504 |
| 56 | MAP2K4 | 0.80095183 |
| 57 | MAPK7 | 0.78807946 |
| 58 | RET | 0.75610385 |
| 59 | MAPK12 | 0.74470251 |
| 60 | CAMK2B | 0.73166525 |
| 61 | PIK3CG | 0.71912031 |
| 62 | CAMK4 | 0.68503740 |
| 63 | PAK2 | 0.66612549 |
| 64 | MARK1 | 0.65107979 |
| 65 | WNK1 | 0.65023476 |
| 66 | TNIK | 0.63925857 |
| 67 | ARAF | 0.63236111 |
| 68 | UHMK1 | 0.62963752 |
| 69 | MET | 0.62645379 |
| 70 | MAP3K10 | 0.61838773 |
| 71 | CAMK1 | 0.59718064 |
| 72 | CDK5 | 0.54757197 |
| 73 | STK4 | 0.53969573 |
| 74 | DAPK3 | 0.53349075 |
| 75 | MAPK4 | 0.53230849 |
| 76 | ROCK2 | 0.52925876 |
| 77 | PRKCH | 0.52111639 |
| 78 | SGK3 | 0.50125981 |
| 79 | AKT3 | 0.49868781 |
| 80 | PKN1 | 0.49060676 |
| 81 | MOS | 0.47168984 |
| 82 | MAPKAPK5 | 0.46600375 |
| 83 | KSR1 | 0.46382476 |
| 84 | SGK2 | 0.44518232 |
| 85 | PRKACB | 0.44274214 |
| 86 | PDPK1 | 0.43699473 |
| 87 | CCNB1 | 0.43678385 |
| 88 | RAF1 | 0.42876200 |
| 89 | PRKCE | 0.42205314 |
| 90 | MARK2 | 0.42073940 |
| 91 | PRKD2 | 0.41955772 |
| 92 | PRKG1 | 0.41655103 |
| 93 | CDK8 | 0.41649078 |
| 94 | RPS6KA6 | 0.40723347 |
| 95 | MAP2K7 | 0.39921641 |
| 96 | EEF2K | 0.39499725 |
| 97 | TRPM7 | 0.39359914 |
| 98 | PRKACA | 0.37662145 |
| 99 | STK11 | 0.37033018 |
| 100 | CAMK1D | 0.36522728 |
| 101 | NTRK3 | 0.36142629 |
| 102 | SGK494 | 0.35948071 |
| 103 | SGK223 | 0.35948071 |
| 104 | DYRK1B | 0.35395500 |
| 105 | PDK1 | 0.34906888 |
| 106 | PTK2B | 0.34520114 |
| 107 | ZAK | 0.34199166 |
| 108 | SGK1 | 0.33778641 |
| 109 | MELK | 0.32859969 |
| 110 | TYRO3 | 0.30619260 |
| 111 | CAMK2G | 0.30380324 |
| 112 | MAP3K1 | 0.30211252 |
| 113 | FLT3 | 0.29835356 |
| 114 | ICK | 0.29208052 |
| 115 | PRKACG | 0.29162602 |
| 116 | RPS6KA3 | 0.28894662 |
| 117 | FER | 0.27487114 |
| 118 | CAMKK1 | 0.26313813 |
| 119 | STK39 | 0.26280557 |
| 120 | MTOR | 0.24864818 |
| 121 | AKT2 | 0.23581660 |
| 122 | RPS6KC1 | 0.23033141 |
| 123 | RPS6KL1 | 0.23033141 |
| 124 | ERBB4 | 0.21457517 |
| 125 | CAMK1G | 0.21020456 |
| 126 | RPS6KA2 | 0.20675850 |
| 127 | RPS6KA1 | 0.19472948 |
| 128 | EPHA4 | 0.19045555 |
| 129 | STK3 | 0.18236480 |
| 130 | HIPK2 | 0.17967688 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.18322295 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.01353545 |
| 3 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.79048127 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.58216355 |
| 5 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.55033456 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.73367536 |
| 7 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.51514664 |
| 8 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.42214981 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.27553011 |
| 10 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.21826038 |
| 11 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.16921385 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.04064165 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 1.84688405 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.74186348 |
| 15 | Huntingtons disease_Homo sapiens_hsa05016 | 1.57525052 |
| 16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.53937411 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.53492902 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.44998410 |
| 19 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.40265980 |
| 20 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.38947955 |
| 21 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.36025224 |
| 22 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.25890945 |
| 23 | Insulin secretion_Homo sapiens_hsa04911 | 1.23392776 |
| 24 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.21887821 |
| 25 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.17661056 |
| 26 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12440808 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.12410778 |
| 28 | Insulin resistance_Homo sapiens_hsa04931 | 1.10492693 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.07335536 |
| 30 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.06065739 |
| 31 | Axon guidance_Homo sapiens_hsa04360 | 1.04171211 |
| 32 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.99895386 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99660149 |
| 34 | Circadian entrainment_Homo sapiens_hsa04713 | 0.99578762 |
| 35 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.99146267 |
| 36 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.97525410 |
| 37 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.97244336 |
| 38 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96823547 |
| 39 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95178194 |
| 40 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.93917567 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.91114151 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89934326 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.89305023 |
| 44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.87556500 |
| 45 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.87432139 |
| 46 | Renin secretion_Homo sapiens_hsa04924 | 0.87131332 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85943816 |
| 48 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.85041112 |
| 49 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.83044091 |
| 50 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.82393031 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.81663340 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.79591964 |
| 53 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79497688 |
| 54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.78522339 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78318595 |
| 56 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.78252816 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.76984251 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.76917408 |
| 59 | Tight junction_Homo sapiens_hsa04530 | 0.75315607 |
| 60 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.73591769 |
| 61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.73247969 |
| 62 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72070940 |
| 63 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68969178 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.68274880 |
| 65 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.66631266 |
| 66 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.64573551 |
| 67 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.63880458 |
| 68 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62977359 |
| 69 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62152204 |
| 70 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.61468560 |
| 71 | Nicotine addiction_Homo sapiens_hsa05033 | 0.61442392 |
| 72 | Taste transduction_Homo sapiens_hsa04742 | 0.60381552 |
| 73 | Bile secretion_Homo sapiens_hsa04976 | 0.59606769 |
| 74 | Adherens junction_Homo sapiens_hsa04520 | 0.59502981 |
| 75 | Gap junction_Homo sapiens_hsa04540 | 0.58307449 |
| 76 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57857918 |
| 77 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.56859152 |
| 78 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.56376058 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.55893953 |
| 80 | Morphine addiction_Homo sapiens_hsa05032 | 0.55656506 |
| 81 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55430682 |
| 82 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55187861 |
| 83 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.55127592 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54945087 |
| 85 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.52415994 |
| 86 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52266755 |
| 87 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.52249092 |
| 88 | Salivary secretion_Homo sapiens_hsa04970 | 0.51967543 |
| 89 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.51625802 |
| 90 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.49218789 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46750843 |
| 92 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.46653196 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.45674291 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.44459116 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.42224153 |
| 96 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.42117524 |
| 97 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41796097 |
| 98 | Pathways in cancer_Homo sapiens_hsa05200 | 0.41503195 |
| 99 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40748616 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.40608272 |
| 101 | Melanogenesis_Homo sapiens_hsa04916 | 0.39902285 |
| 102 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.39297619 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.38537121 |
| 104 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.38018543 |
| 105 | Endometrial cancer_Homo sapiens_hsa05213 | 0.37935337 |
| 106 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.37625115 |
| 107 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37622200 |
| 108 | Long-term depression_Homo sapiens_hsa04730 | 0.37320133 |
| 109 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.37234344 |
| 110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.36463750 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.35898684 |
| 112 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35467327 |
| 113 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.35431326 |
| 114 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.33564622 |
| 115 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33119887 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.32493284 |
| 117 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.31556193 |
| 118 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31534331 |
| 119 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31048370 |
| 120 | Glioma_Homo sapiens_hsa05214 | 0.30952112 |
| 121 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28332827 |
| 122 | Galactose metabolism_Homo sapiens_hsa00052 | 0.27813249 |
| 123 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27044363 |

